A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
AIM: To examine the safety and efficacy of modafinil (200 mg/day) compared to placebo in the treatment of methamphetamine dependence and to examine predictors of post-treatment outcome. PARTICIPANTS AND DESIGN: Eighty methamphetamine-dependent subjects in Sydney, Australia were allocated randomly to...
| Publicado en: | Addiction Vol. 104; no. 2; pp. 224 - 234 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | clinical trial research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Feb2009
|
| Acceso en línea: | Ver este registro en EBSCOhost |